Why SmileDirectClub’s New Patent Is a Big Deal

By Chris Lange Updated Jul 13, 7:55AM EDT · Published Apr 28, 1:09PM EDT

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Why SmileDirectClub’s New Patent Is a Big Deal — © scyther5 / Getty Images

SmileDirectClub Inc. (NASDAQ: SDC) shares pushed higher on Tuesday after the company announced that it had received a patent for its new retail plan. The patent specifically deals with the firm’s SmileShop intellectual property.

Ultimately, this patent, U.S. Patent No. 10,636,522, further strengthens SmileDirectClub’s efforts to bring affordable, accessible oral care to more people through its unique and innovative teledentistry platform and direct-to-consumer business model.

In simpler terms, the patent ensures no clear aligner competitor will be able to duplicate SmileDirectClub’s unique model for 18 years.

The patent encompasses the unique SmileShop concept and process, including scheduling of an appointment at a SmileShop, sending the scheduling confirmation to the customer, conducting the intraoral scan, generating a treatment plan, receiving approval of the treatment plan by a licensed dentist or orthodontist, producing aligners in accordance with the treatment plan, and sending those aligners to the customer.

[nativounit]

The company also announced it is making plans to slowly reopen its SmileShops beginning in May in the United States, Canada, Germany, Australia, New Zealand, the United Kingdom and Ireland as local governments begin to lift business restrictions.

David Katzman, CEO of SmileDirectClub, commented:

This patent designation is a significant validation of our unique customer-oriented care model, and expands our category ownership, including the manufacturing and retail experience. SmileDirectClub is continually seeking to improve the affordability and accessibility of oral care for consumers. As the industry pioneer and inventor of the SmileShop concept, this patent is recognition that SmileDirectClub offers an innovative way for consumers to access oral care that is safe, doctor-directed and convenient. We look forward to welcoming customers back to our SmileShops at the earliest and safest possible time.

SmileDirectClub stock traded up about 18% to $6.35 on Tuesday, in a 52-week range of $3.64 to $21.10.

[recirclink id=703629][wallst_email_signup]

About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.